flsi official statement
March 09, 2021


Faberco Life Sciences, Inc, in partnership with Serum Institute of India (SII) is making CovovaxTM, the COVID-19 vaccine developed by Novavax available in the Philippines.

It has come to our attention a claim made by a local government official that “Mikey Arroyo received the Covovax vaccine.” The company assures the public that this claim is entirely false and inaccurate and the same has been denied by Representative Arroyo himself.

Faberco has not imported or brought into the country even a single vial of the Covovax vaccine.

Faberco Life Sciences, Inc, abides by all the rules and regulations with regards to obtaining an Emergency Use Authorization (EUA). We assure the public that the importation by our company of CovovaxTM vaccine will be in strict compliance with the laws of the Government of the Philippines.